MXPA05010707A - Combinaciones que comprenden farmacos anti-epilepticos para el tratamiento de desordenes neurologicos. - Google Patents
Combinaciones que comprenden farmacos anti-epilepticos para el tratamiento de desordenes neurologicos.Info
- Publication number
- MXPA05010707A MXPA05010707A MXPA05010707A MXPA05010707A MXPA05010707A MX PA05010707 A MXPA05010707 A MX PA05010707A MX PA05010707 A MXPA05010707 A MX PA05010707A MX PA05010707 A MXPA05010707 A MX PA05010707A MX PA05010707 A MXPA05010707 A MX PA05010707A
- Authority
- MX
- Mexico
- Prior art keywords
- combinations
- treatment
- neurological disorders
- epileptic drugs
- epileptic
- Prior art date
Links
- 208000012902 Nervous system disease Diseases 0.000 title abstract 2
- 208000025966 Neurological disease Diseases 0.000 title abstract 2
- 239000001961 anticonvulsive agent Substances 0.000 title abstract 2
- 230000003556 anti-epileptic effect Effects 0.000 abstract 1
- 229960003965 antiepileptics Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0307860.7A GB0307860D0 (en) | 2003-04-04 | 2003-04-04 | Organic compounds |
| PCT/EP2004/003518 WO2004087161A1 (en) | 2003-04-04 | 2004-04-02 | Combinations comprising anti-epileptic drugs for the treatment of neurological disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05010707A true MXPA05010707A (es) | 2005-12-12 |
Family
ID=9956223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05010707A MXPA05010707A (es) | 2003-04-04 | 2004-04-02 | Combinaciones que comprenden farmacos anti-epilepticos para el tratamiento de desordenes neurologicos. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20060194766A1 (https=) |
| EP (1) | EP1620103A1 (https=) |
| JP (1) | JP2006522062A (https=) |
| CN (1) | CN100546581C (https=) |
| AU (1) | AU2004226825B2 (https=) |
| BR (1) | BRPI0409170A (https=) |
| CA (1) | CA2521274A1 (https=) |
| GB (1) | GB0307860D0 (https=) |
| MX (1) | MXPA05010707A (https=) |
| WO (1) | WO2004087161A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060252745A1 (en) | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
| GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
| CA2690110A1 (en) * | 2007-07-13 | 2009-01-22 | Eisai R&D Management Co., Ltd. | Ampa receptor antagonists for neuropathic pain |
| WO2009015244A1 (en) * | 2007-07-23 | 2009-01-29 | Synosia Therapeutics | Rufinamide for the treatment of post-traumatic stress disorder |
| US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
| PT3061821T (pt) | 2009-07-22 | 2019-09-05 | PureTech Health LLC | Composições para tratamento de distúrbios melhorados por ativação de recetores muscarínicos |
| KR102408292B1 (ko) | 2018-09-28 | 2022-06-10 | 카루나 세러퓨틱스 인코포레이티드 | 무스카린성 수용체 활성화에 의해 개선된 장애의 치료를 위한 조성물 및 방법 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB864536A (en) * | 1957-11-06 | 1961-04-06 | Sapos S A Lab | ª‡-ethyl-phenylacetylurea |
| GB1028234A (en) * | 1964-01-06 | 1966-05-04 | Ici Ltd | New pharmaceutical compositions comprising 5-aminodibenzocycloheptene derivatives |
| JPH02502546A (ja) * | 1987-12-22 | 1990-08-16 | ファーカニー、ジョン ダブリュ | 抗ひきつけ剤組成物および方法のためのデキストロルファン相乗的協力剤 |
| US5095033A (en) * | 1991-03-01 | 1992-03-10 | Laboratoires Biocodex | Method for treating epilepsy |
| IT1261808B (it) * | 1993-07-06 | 1996-06-03 | Impiego di l-carnitina o acido l-carnitine e valproato nel trattamentodei disosrdini convulsivi | |
| EP0946597B1 (en) * | 1996-10-19 | 2003-08-13 | University Of Wales, Bangor | Preparation of chemically reactive starch |
| CA2269807C (en) * | 1996-10-24 | 2007-04-10 | Novartis Ag | Substituted aminoalkanephosphonic acids |
| US6306909B1 (en) * | 1997-03-12 | 2001-10-23 | Queen's University At Kingston | Anti-epileptogenic agents |
| CN1265889A (zh) * | 1999-03-06 | 2000-09-13 | 王学勇 | 一种治疗癫痫病的药物 |
| AR026610A1 (es) * | 1999-12-01 | 2003-02-19 | Ucb Sa | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central |
| US6191117B1 (en) * | 2000-07-10 | 2001-02-20 | Walter E. Kozachuk | Methods of producing weight loss and treatment of obesity |
| ES2314111T3 (es) * | 2001-11-12 | 2009-03-16 | Novartis Ag | Monohidroxicarbamezepina para uso en la preparacion de un medicamento para el tratamiento del trastorno de afectivo y de atencion y dolor neuropatico. |
-
2003
- 2003-04-04 GB GBGB0307860.7A patent/GB0307860D0/en not_active Ceased
-
2004
- 2004-04-02 CN CNB2004800092188A patent/CN100546581C/zh not_active Expired - Fee Related
- 2004-04-02 MX MXPA05010707A patent/MXPA05010707A/es not_active Application Discontinuation
- 2004-04-02 CA CA002521274A patent/CA2521274A1/en not_active Abandoned
- 2004-04-02 AU AU2004226825A patent/AU2004226825B2/en not_active Ceased
- 2004-04-02 JP JP2006504970A patent/JP2006522062A/ja active Pending
- 2004-04-02 US US10/550,381 patent/US20060194766A1/en not_active Abandoned
- 2004-04-02 WO PCT/EP2004/003518 patent/WO2004087161A1/en not_active Ceased
- 2004-04-02 BR BRPI0409170-1A patent/BRPI0409170A/pt not_active IP Right Cessation
- 2004-04-02 EP EP04725366A patent/EP1620103A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006522062A (ja) | 2006-09-28 |
| CN100546581C (zh) | 2009-10-07 |
| GB0307860D0 (en) | 2003-05-14 |
| AU2004226825B2 (en) | 2007-08-16 |
| US20060194766A1 (en) | 2006-08-31 |
| WO2004087161A1 (en) | 2004-10-14 |
| BRPI0409170A (pt) | 2006-04-11 |
| EP1620103A1 (en) | 2006-02-01 |
| AU2004226825A1 (en) | 2004-10-14 |
| CN1767832A (zh) | 2006-05-03 |
| CA2521274A1 (en) | 2004-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY127290A (en) | New use of flibanserin | |
| EP1558220A4 (en) | ORAL COMPOSITIONS FOR THE TREATMENT OF DISEASES | |
| WO2005002515A3 (en) | Delivery of therapeutic compounds to the brain and other tissues | |
| SG166820A1 (en) | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders | |
| SE0303571D0 (sv) | Medical product for moisture-sensitive medicaments | |
| WO2004043341A3 (en) | Treatment for hemorrhagic shock | |
| MXPA05012358A (es) | Combinacion farmaceutica que comprende modafinilo y otra droga. | |
| WO2004087880A3 (en) | Compounds and their use to treat diabetes and related disorders | |
| IL157226A0 (en) | Composition and method for potentiating drugs | |
| WO2004073615A8 (en) | Deazaflavin compounds and methods of use thereof | |
| MXPA05010707A (es) | Combinaciones que comprenden farmacos anti-epilepticos para el tratamiento de desordenes neurologicos. | |
| TW200628473A (en) | Novel heterocycles | |
| BG108452A (en) | Tablet comprising cetirizine and pseudoephedrine | |
| WO2005004854A3 (fr) | Utilisation de la betaine pour le traitement des arterites | |
| WO2005092062A3 (en) | Compounds for neurodegenerative disorders | |
| IL168308A (en) | Compositions containing roflumilast and formoterol | |
| UA90504C2 (ru) | Лекарственное средство для лечения заболеваний дыхательных путей | |
| WO2005081972A3 (en) | Maleiimide anti-tumor phosphatase inhibitors | |
| MXPA05007253A (es) | Sales novedosas de derivados anticonvulsivantes. | |
| WO2005020904A3 (en) | Oral neurotherapeutic cefazolin compositions | |
| UA83017C2 (uk) | Комбінація рофлуміласту та r,r-формотеролу для лікування захворювань дихальних шляхів | |
| WO2008014232A3 (en) | Pharmaceutical formulations for the treatment of alzheimer's disease | |
| MXPA05003844A (es) | Compuestos con base de glucosa con afinidad para p-selectina. | |
| MXPA03010919A (es) | Uso de acetil l-carnitina para preparacion de medicamento para terapia preventiva del dolor. | |
| WO2003059394A3 (fr) | Compositions pour la vectorisation d'oligonucleotides a travers la barriere hematoencephalique et leur utilisatin pour le traitement des maladies du systeme nerveux central |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |